Testing the safety and effectiveness of a vaccine that protects people from a certain kind of infection (pneumococcal disease) after adding a preservative to the vaccine

Final Infant Series Report: A Phase 3, Randomized, Open-Label Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Formulated in Multi-Dose Vials Given With Routine Pediatric Vaccinations in Healthy Infants

Category & Conditions:
Vaccine-related Conditions
Medicine:
PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B4671001
Open Plain Language Summary Result:Click here